These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25106135)

  • 41. Insulin lung deposition and clearance following Technosphere® insulin inhalation powder administration.
    Cassidy JP; Amin N; Marino M; Gotfried M; Meyer T; Sommerer K; Baughman RA
    Pharm Res; 2011 Sep; 28(9):2157-64. PubMed ID: 21491144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of lactose carrier on the powder behavior and aerodynamic performance of bosentan microparticles for dry powder inhalation.
    Lee HJ; Lee HG; Kwon YB; Kim JY; Rhee YS; Chon J; Park ES; Kim DW; Park CW
    Eur J Pharm Sci; 2018 May; 117():279-289. PubMed ID: 29510172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lecithin/TPGS-based spray-dried self-microemulsifying drug delivery systems: In vitro pulmonary deposition and cytotoxicity.
    Ishak RA; Osman R
    Int J Pharm; 2015 May; 485(1-2):249-60. PubMed ID: 25772421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhaled insulin--does it become reality?
    Siekmeier R; Scheuch G
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G; Vanderbist F; Amighi K
    Int J Pharm; 2009 Jan; 365(1-2):162-9. PubMed ID: 18782609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of water to ethanol feed ratio on physical properties and aerosolization behavior of spray dried cromolyn sodium particles.
    Gilani K; Najafabadi AR; Barghi M; Rafiee-Tehrani M
    J Pharm Sci; 2005 May; 94(5):1048-59. PubMed ID: 15793812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
    Wanning S; Süverkrüp R; Lamprecht A
    Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Good Things in Small Packages: an Innovative Delivery Approach for Inhaled Insulin.
    Fink JB; Molloy L; Patton JS; Galindo-Filho VC; de Melo Barcelar J; Alcoforado L; Brandão SCS; de Andrade AD
    Pharm Res; 2017 Dec; 34(12):2568-2578. PubMed ID: 28718049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
    Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
    Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides.
    Hussain A; Majumder QH; Ahsan F
    Pharm Res; 2006 Jan; 23(1):138-47. PubMed ID: 16320001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
    Chan HK; Clark A; Gonda I; Mumenthaler M; Hsu C
    Pharm Res; 1997 Apr; 14(4):431-7. PubMed ID: 9144727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Manufacturing of High-Concentration Monoclonal Antibody Formulations via Spray Drying-the Road to Manufacturing Scale.
    Gikanga B; Turok R; Hui A; Bowen M; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2015; 69(1):59-73. PubMed ID: 25691715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a dextran-budesonide prodrug for inhalation therapy.
    Waters RC; Hochhaus G
    Eur J Pharm Sci; 2019 Mar; 129():58-67. PubMed ID: 30521945
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.